Natarajan Sethuraman - 28 Oct 2021 Form 3 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role: Chief Scientific Officer
Signature: /s/ Jared Cohen, as Attorney-in-fact
Issuer symbol: TRDA
Transactions as of: 28 Oct 2021
Net transactions value: $0
Form type: 3
Filing time: 28 Oct 2021, 21:01:50 UTC
Next filing: 03 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TRDA	Common Stock						144,762	28 Oct 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TRDA	Stock Option (Right to Buy)							28 Oct 2021	Common Stock	68,312	$1.74	Direct	F2
holding	TRDA	Stock Option (Right to Buy)							28 Oct 2021	Common Stock	10,284	$2.10	Direct	F3
holding	TRDA	Stock Option (Right to Buy)							28 Oct 2021	Common Stock	96,377	$8.47	Direct	F4
holding	TRDA	Stock Option (Right to Buy)							28 Oct 2021	Common Stock	4,146	$12.52	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of (i) 114,006 shares of common stock and (ii) 30,756 shares of restricted common stock issued upon early exercise of stock options.
F2	25% of the shares subject to this option vested and became exercisable on March 4, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F3	25% of the shares subject to this option shall vest and become exercisable on August 12, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F4	25% of the shares subject to this option shall vest and become exercisable on March 30, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F5	25% of the shares subject to this option shall vest and become exercisable on August 2, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.